
Sign up to save your podcasts
Or


In this episode, we explore the role of adjuvants in vaccines. These addatives help the immune response to a vaccine, making it more effective at stoping infection, complication, hospitalization, and or death. We discuss the need for better vaccines and how adjuvants may be able to help.
References:
Grohskopf, L. A. (2019). Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2019–20 influenza season. MMWR. Recommendations and Reports, 68. https://www.cdc.gov/mmwr/volumes/73/rr/rr7305a1.htm
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995). The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Annals of Internal medicine, 123(7), 518-527. https://www.ncbi.nlm.nih.gov/books/NBK66348/
Puig-Barbera, J., Diez-Domingo, J., Arnedo-Pena, A., Ruiz-Garcia, M., Perez-Vilar, S., Mico-Esparza, J. L., ... & Schwarz-Chavarri, H. (2012). Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case–case comparison, case-control study. Vaccine, 30(39), 5714-5720. https://www.sciencedirect.com/science/article/pii/S0264410X12010079
Kwong, J. C., Campitelli, M. A., Gubbay, J. B., Peci, A., Winter, A. L., Olsha, R., ... & Crowcroft, N. S. (2013). Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010–2011 season. Clinical infectious diseases, 57(6), 820-827. https://academic.oup.com/cid/article/57/6/820/330306
Wilson, K. L., Xiang, S. D., & Plebanski, M. (2017). Inflammatory/noninflammatory adjuvants and nanotechnology—The secret to vaccine design. In Micro and nanotechnology in vaccine development (pp. 99-125). William Andrew Publishing. https://www.sciencedirect.com/science/article/pii/B9780323399814000063
Schijns, V. E. (2000). Immunological concepts of vaccine adjuvant activity: Commentary. Current opinion in immunology, 12(4), 456-463. https://doi.org/10.1016/S0952-7915(00)00120-5
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
By MedEvidence ArticlesIn this episode, we explore the role of adjuvants in vaccines. These addatives help the immune response to a vaccine, making it more effective at stoping infection, complication, hospitalization, and or death. We discuss the need for better vaccines and how adjuvants may be able to help.
References:
Grohskopf, L. A. (2019). Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2019–20 influenza season. MMWR. Recommendations and Reports, 68. https://www.cdc.gov/mmwr/volumes/73/rr/rr7305a1.htm
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995). The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Annals of Internal medicine, 123(7), 518-527. https://www.ncbi.nlm.nih.gov/books/NBK66348/
Puig-Barbera, J., Diez-Domingo, J., Arnedo-Pena, A., Ruiz-Garcia, M., Perez-Vilar, S., Mico-Esparza, J. L., ... & Schwarz-Chavarri, H. (2012). Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case–case comparison, case-control study. Vaccine, 30(39), 5714-5720. https://www.sciencedirect.com/science/article/pii/S0264410X12010079
Kwong, J. C., Campitelli, M. A., Gubbay, J. B., Peci, A., Winter, A. L., Olsha, R., ... & Crowcroft, N. S. (2013). Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010–2011 season. Clinical infectious diseases, 57(6), 820-827. https://academic.oup.com/cid/article/57/6/820/330306
Wilson, K. L., Xiang, S. D., & Plebanski, M. (2017). Inflammatory/noninflammatory adjuvants and nanotechnology—The secret to vaccine design. In Micro and nanotechnology in vaccine development (pp. 99-125). William Andrew Publishing. https://www.sciencedirect.com/science/article/pii/B9780323399814000063
Schijns, V. E. (2000). Immunological concepts of vaccine adjuvant activity: Commentary. Current opinion in immunology, 12(4), 456-463. https://doi.org/10.1016/S0952-7915(00)00120-5
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!